IDH1 and myeloid neoplasm: A prime example is the availability of IDH inhibitors for IDH1/2-mutated myeloid neoplasms.29 Hopefully with time, molecular testing at diagnosis will not only help with disease prognostication but will also help offer better therapeutic approaches.